Ls Investment Advisors, LLC Dexcom Inc Transaction History

Ls Investment Advisors, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$80.99 - $107.93 $199,478 - $265,831	-2,463 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$84.79 - $104.74 $30,270 - $37,392	-357 Reduced 12.66%	2,463 $885,000
Q4 2020 Feb 10, 2021	BUY	$78.0 - $104.5 $40,170 - $53,817	515 Added 22.34%	2,820 $1.04 Million
Q3 2020 Nov 12, 2020	BUY	$95.51 - $112.95 $573 - $677	6 Added 0.26%	2,305 $950,000
Q2 2020 Aug 10, 2020	BUY	$62.68 - $105.34 $139,400 - $234,276	2,224 Added 2965.33%	2,299 $932,000
Q1 2020 Apr 20, 2020	SELL	$47.79 - $75.63 $24,611 - $38,949	-515 Reduced 87.29%	75 $20,000
Q3 2019 Oct 31, 2019	BUY	$35.53 - $43.8 $1,065 - $1,314	30 Added 5.36%	590 $88,000
Q4 2018 Feb 01, 2019	BUY	$26.99 - $37.37 $15,114 - $20,927	560 New	560 $67,000
Q4 2017 Feb 07, 2018	SELL	$11.12 - $15.38 $15,223 - $21,055	-1,369 Closed	0 $0
Q3 2017 Oct 19, 2017	BUY	$11.36 - $18.98 $15,551 - $25,983	1,369	1,369 $67,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Ls Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Ls Investment Advisors, LLC with notifications on news.